Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Skin infections and eczema were most common in all ages, acne in teens and young adults, and nutritional skin problems and infestations in children.

The document lists various dermatology topics, treatments, and diagnostic methods.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

The exam tested knowledge on various skin-related topics for CME credit.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Immune cells are crucial for hair growth and preventing hair loss.

Genetic testing is crucial for diagnosing congenital atrichia, a rare condition causing irreversible hair loss.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

The document is a detailed medical reference on skin and genetic disorders.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

The document provides 70 multiple choice questions to improve haematology skills.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.